Characterization of the chylomicron‐remnant‐recognition sites on parenchymal and Kupffer cells of rat liver Selective inhibition of parenchymal cell recognition by lactoferrin
- 1 April 1992
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 205 (2) , 775-784
- https://doi.org/10.1111/j.1432-1033.1992.tb16842.x
Abstract
Upon injection of chylomicrons into rats, chylomicron remnants are predominantly taken up by parchenymal cells, with a limited contribution (8.6% of the injected dose) by Kupffer cells. In vitro storage of partially processed chylomicron remnants for only 24 h leads, after in vivo injection, to an avid recognition by Kupffer cells (uptake up to 80% of the total liver‐associated radioactivity). Lactoferrin greatly reduces the liver uptake of chylomicron remnants, which appears to be the consequence of a specific inhibition of the uptake by parenchymal cells. Kupffer‐cell uptake is not influenced by lactoferrin. In vitro studies with isolated parenchymal and Kupffer cells show that both contain a specific recognition site for chylomicron remnants. The Kupffer‐cell recognition site differs in several ways from the recognition site on parenchymal cells as follows. (a) The maximum level of binding is 3.7‐fold higher/mg cell protein than with parenchymal cells. (b) Binding of chylomicron remnants is partially dependent on the presence of calcium, while binding to parenchymal cells is not. (c) β‐Migrating very‐low‐density lipoprotein is a less effective competitor for chylomicron‐remnant binding to Kupffer cells compared to parenchymal cells. (d) Lactoferrin leaves Kupffer‐cell binding uninfluenced, while it greatly reduces binding of chylomicron remnants to parenchymal cells. The properties of chylomicron‐remnant recognition by parenchymal cells are consistent with apolipoprotein E being the determinant for recognition. It can be concluded that the chylomicron‐remnant recognition site on Kupffer cells possesses properties which are distinct from the recognition site on parenchymal cells. It might be suggested that partially processed chylomicron remnants are specifically sensitive to a modification, which induces an avid interaction with the Kupffer cells. The recognition site for (modified) chylomicron remnants on Kupffer cells might function as a protection system against the occurrence of these potential atherogenic chylomicron‐remnant particles in the blood.Keywords
This publication has 40 references indexed in Scilit:
- Evidence that the newly cloned low‐density‐lipoprotein receptor related protein (LRP) is the α2‐macroglobulin receptorFEBS Letters, 1990
- The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding proteinNature, 1989
- Interaction of β‐very‐low‐density lipoproteins with rat liver cellsEuropean Journal of Biochemistry, 1989
- Lipoprotein binding to cultured human hepatoma cells.Journal of Clinical Investigation, 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Distinct Hepatic Receptors for Low Density Lipoprotein and Apolipoprotein E in HumansScience, 1985
- Discrepancies in the catabolic pathways of rat and human low density lipoproteins as revealed by partial hepatectomy in the ratAtherosclerosis, 1978
- Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.Journal of Clinical Investigation, 1975
- Distributio of chylomicron cholesteryl ester between parenchymal and Kupffer cells of rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1971
- Efficient Trace-labelling of Proteins with IodineNature, 1958